Docket Room.
S 4222·NJ·senate

Improves access to lower-cost generic and biosimilar drugs.

In CommitteeFiled May 14, 2026
Sponsor: Gordon Johnson (D)
Latest Action

Introduced First Reading Senate Referred to SCM

May 14, 2026

Email me when S 4222 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track S 4222. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill forces Medicaid managed‑care groups, state health‑benefits vendors, and school‑employee plans to put cheaper generic and biosimilar drugs on their formularies with better cost‑sharing and no extra restrictions. It also mandates that these organizations publish an up‑to‑date, easy‑to‑access drug list. The goal is to lower prescription costs for patients while preserving clinical discretion.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about S 4222

3 free questions a day, no account

History

  1. Introduced in the Senate, Referred to Senate Commerce Committee

Sponsors

  • Gordon Johnson (D) · sponsor
  • Johnson, Gordon M.

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when S 4222 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track S 4222 free

Or ask your AI assistant about S 4222 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice